Kymera Therapeutics Inc’s recent filing unveils that its Director Booth Bruce unloaded Company’s shares for reported $2.9 million on Mar 15 ’24. In the deal valued at $40.46 per share,71,764 shares were sold. As a result of this transaction, Booth Bruce now holds 806,697 shares worth roughly $28.81 million.
Then, Booth Bruce sold 55,779 shares, generating $2,229,927 in total proceeds. Upon selling the shares at $39.98, the Director now owns 819,151 shares.
Before that, Booth Bruce sold 139,255 shares. Kymera Therapeutics Inc shares valued at $5,880,415 were divested by the Director at a price of $42.23 per share. As a result of the transaction, Booth Bruce now holds 828,830 shares, worth roughly $29.6 million.
Oppenheimer initiated its Kymera Therapeutics Inc [KYMR] rating to an Outperform in a research note published on April 22, 2024; the price target was $53. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid February with a ‘”a Peer perform”‘ rating. JP Morgan also remained covering KYMR and has increased its forecast on January 04, 2024 with a “an Overweight” recommendation from previously “Neutral” rating. BofA Securities revised its rating on January 03, 2024. It rated KYMR as “a Neutral” which previously was an “a Buy”.
Price Performance Review of KYMR
On Tuesday, Kymera Therapeutics Inc [NASDAQ:KYMR] saw its stock jump 3.96% to $35.71. Over the last five days, the stock has gained 5.25%. Kymera Therapeutics Inc shares have risen nearly 40.26% since the year began. Nevertheless, the stocks have risen 2.50% over the past one year. While a 52-week high of $45.31 was reached on 02/27/24, a 52-week low of $9.60 was recorded on 01/04/24. SMA at 50 days reached $38.98, while 200 days put it at $25.47. A total of 0.44 million shares were traded, compared to the trading of 0.42 million shares in the previous session.
Levels Of Support And Resistance For KYMR Stock
The 24-hour chart illustrates a support level at 34.47, which if violated will result in even more drops to 33.22. On the upside, there is a resistance level at 36.98. A further resistance level may holdings at 38.25. The Relative Strength Index (RSI) on the 14-day chart is 45.88, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.75, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 47.95%. Stochastics %K at 30.20% indicates the stock is a holding.
